Restricted Party Screening definition

Restricted Party Screening includes, but is not limited to, the comparison of any individual or entity directly or indirectly involved in activities under this Agreement, against the applicable Restricted Party Lists.

Restricted Party Screening means the comparison of any Person directly or indirectly involved in activities conducted under or covered by this Agreement, against the Restricted Party Lists.

Restricted Party Screening or “RPS”). If Mimecast considers, in its sole discretion, but acting reasonably based on its standard RPS process, that the results of the RPS in relation to Customer are unsatisfactory, Mimecast may terminate this Agreement and any Services Order related hereto with immediate effect upon written notice to Customer. Upon termination pursuant to this Section 8.2(c), Mimecast shall have no further obligations to Customer hereunder.

Examples of Restricted Party Screening in a sentence

• Each Party shall conduct Restricted Party Screening of the names and addresses of all employees and subcontractors invited to participate in activities under this Agreement by that Party, and shall require its subcontractors to conduct such screening of its employees and subcontractors or represent that no such subcontractor or employee is on an applicable Restricted Party List.

• I understand that I will be subject to Restricted Party Screening before and during the term of my visit and that, in relation to this screening, the University, at its sole discretion and at any time, may deny me access to the facilities at the University.

• Restricted Party Screening is conducted by multiple offices according to their roles in the academic enterprise.

• In addition, some offices at Princeton University utilize other vendors, such as HireRight, to perform Restricted Party Screening.

• For example, all individuals affiliated with the University who work with international persons and entities must confirm via Restricted Party Screening and consultation with Export Control that activities are permitted with collaborators.Liaison Program: Export Control works closely with various Liaison Administrators across campus.

• Restricted Party Screening (RPS) involves searching these lists for names of individuals, entities, and countries.

• EXCLUSION SCREENING Vapotherm will screen Employee applicants and proposed Covered Contractors against the Restricted Party Screening Authorities.

• The export control compliance software performs Restricted Party Screening against all relevant U.S. Government lists, including: Department of Treasury Office of Foreign Assets Control (OFAC) Sanctions, Department of Commerce Bureau of Industry and Security (BIS) Denied Persons List, Department of Commerce BIS Entity List and Unverified List, Department of State Arms Export Control Act Debarred Parties, Department of State Designated Terrorist Organizations, Department of State Nonproliferation Orders.

• Restricted Party Screening is an essential component of complying with government regulations concerning persons debarred or excluded from participation in certain activities.

• All personnel with access to the controlled technology and their nationality are listed in the TCP Certification Form and a Restricted Party Screening has been completed.

More Definitions of Restricted Party Screening

Restricted Party Screening means screening a proposed VISITOR name or VISITOR INSTITUTION name through the UNIVERSITY’S Export Control Officer for final approval and clearance to engage in RESEARCH as contemplated in this Agreement and for Export Control Compliance.

Restricted Party Screening means the comparison of any individual or entity directly or indirectly involved in the Study, against the relevant Restricted Party Lists. By accepting payment for this program from Pfizer, you certify to the representations set forth herein, and agree to abide by all requirements set forth herein. Agreed to by: PFIZER IGLC Printed Name Title INSTITUTION Prof. Xxxxxxxxx XxxxxxX'Xxxxxxxxx Chief of the Department of Human Pathology of Adulthood and Childhood “X. Xxxxxxx” of the University of Xxxxxxx Read and Acknowledged by: XxxxXxxxxxxx Xxxxx, MD, PhD Payments to be disbursed upon reaching the agreed upon milestones detailed below and updating the status in the Pfizer online Grant Management System (GMS). Milestone Due Date Description Payment Amount Payment Disbursed - Initial Payment $45,000.00 February 1, 2018 Study status update report $15,000.00 Ninety (90) days after submission April 30, 2019 Final Payment upon receipt of Study Report due within six (6) months of Study Conduct Completion Date October 31, 2018 $15,000.00 Ninety (90) days after submission Prior to each milestone, Institution/Principal Investigator will receive an email requesting the Institution/Principal Investigator to log into the GMS to enter the Study status update report and upload any relevant supporting documentation. Once the Study status update report (or Study Report following the project’s completion) is reviewed and deemed to be complete by Pfizer, payment will be scheduled to be paid in 60 days (corporate payment terms). If upon review it is determined the milestone delivery has not been satisfactorily met as originally defined, Pfizer retains the right to modify the payment amount and/or scheduled disbursement date and future milestones as appropriate. Initial Payment – Pfizer will make no initial payment until Pfizer has received (1) an executed copy of the Agreement and (2) the required documents identified in Attachment B, Study Documentation Requirements.